CLINICAL_TRIALS
trial_result
· 2021-05-11
Clinical Trial Update: Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab [Phase 2]
Summary
A Phase 2 trial evaluating denosumab for skeletal disease in type 2 diabetes was terminated, with results posted in May 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mishaela Rubin | Conditions: Diabetes Mellitus, Type 2, Osteoporosis | Phase 2 | Status: TERMINATED | Results posted: 2021-05-11